Overview
A Certificate of Analysis (COA) is the primary analytical document accompanying a research peptide lot. It records independently generated test results that characterize the compound's purity and molecular identity for research purposes.
This guide provides a structured checklist for reviewing COA documentation in a laboratory research context. Understanding each field on a COA helps researchers confirm the document applies to the material received, interpret analytical data correctly, and identify documentation that warrants follow-up. This checklist is for laboratory research use — not for clinical, diagnostic, or consumer applications.
---
What a Peptide COA Is
A Certificate of Analysis is a per-lot document issued by an analytical laboratory that has tested a specific production batch of a research compound. For synthetic peptides, a standard research-grade COA typically records:
- The identity of the compound and the production lot
- HPLC purity: the chromatographic purity percentage of the main compound
- LC-MS identity: the observed molecular weight compared to the theoretical value
- Physical appearance of the lyophilized material
- Storage conditions
- Testing date and, where available, laboratory information
A COA is a point-in-time characterization of a specific lot — it does not certify ongoing stability, future purity, or suitability for any use outside a laboratory research context. See Understanding Certificates of Analysis for a complete field-by-field walkthrough, and How to Verify a Peptide COA for cross-checking methodology.
---
COA Checklist: Key Fields to Review
Use this checklist when reviewing COA documentation for a research peptide lot:
Document-level:- Product name or compound name is stated and matches the vial label
- Lot or batch number is present and traceable to the specific vial or order
- Test date is recorded and is within a reasonable reference window
- Issuing laboratory is identified (name or independent third-party designation where available)
- Document appears internally consistent — fields do not contradict each other
- HPLC purity percentage is reported
- Chromatogram is included or referenced
- Main peak is clearly identified and its area percentage stated
- Impurity peaks, if any, are identified or their combined area noted
- Observed molecular weight (m/z-derived) is reported
- Theoretical molecular weight for the stated compound is listed
- The deviation between observed and theoretical is within acceptable tolerance (typically ±1 Da)
- Physical appearance of the lyophilized material is described (e.g., white to off-white powder)
- Recommended storage conditions are stated
- Any special handling notes are present where applicable
---
Product Name, Lot Number, and Date
Product name: Confirm the compound name on the COA matches the vial label and the order documentation. For compounds with multiple salt forms or modifications, the name should specify which form was tested. Lot or batch number: The lot number ties the COA to a specific production run. Cross-reference the lot number on the COA against the lot number on the vial or packing documentation. A COA issued for a different lot than the material received is not analytically applicable to the current batch. Test date: The test date establishes when the analytical characterization was performed. A recent test date is more directly relevant to the current condition of the material. For background on how storage time relates to analytical stability, see Peptide Stability and Degradation in Research Context.---
HPLC Purity and Chromatogram Review
HPLC purity percentage is expressed as the proportion of the UV-detected chromatographic area attributable to the main compound peak. A higher purity percentage indicates a smaller proportion of related substances in the sample.When reviewing HPLC data on a COA:
Main peak: The peak corresponding to the target compound should be clearly identified, typically by retention time and area percentage. This is the headline purity figure on the COA. Impurity peaks: Any peaks other than the main peak represent related substances — truncated sequences, oxidized variants, deletion peptides, or synthesis-related impurities. Their combined area subtracted from 100% represents the impurity content. Chromatogram availability: Where a chromatogram image is included, it provides direct visual confirmation of the peak profile. A summary percentage without a chromatogram provides less information for independent cross-verification.For a detailed guide to reading HPLC chromatograms, peak area normalization, and impurity interpretation, see How to Read HPLC Purity Data.
---
LC-MS Identity Confirmation
LC-MS identity data provides molecular weight confirmation. The COA should show: Observed molecular weight: Measured from the mass-to-charge ratio (m/z) and charge state data from the mass spectrometer — this represents the detected mass of the dominant species in the sample. Theoretical molecular weight: Calculated from the compound's amino acid sequence and known modifications. This is the mass the compound should have based on its structure. Match tolerance: A match within approximately ±0.5–1.0 Da is generally acceptable for a synthetic peptide. A significant mismatch warrants follow-up with the supplier.LC-MS confirms molecular identity — it answers "Is this the right compound?" HPLC confirms chromatographic purity — it answers "How pure is this sample?" The two tests address different questions and are complementary. For a dedicated guide to reading LC-MS data, see LC-MS Identity Confirmation. For a comparison of both methods, see HPLC vs LC-MS: A Researcher's Comparison.
---
Appearance, Storage, and Handling Notes
Appearance: The COA describes the physical appearance of the lyophilized material, typically "white to off-white powder" or similar. Comparing the received material to the COA appearance description is a simple visual check. Significant deviations may indicate storage or handling issues. Storage conditions: The COA or accompanying documentation specifies recommended storage conditions (temperature, light, moisture exposure). Following the specified conditions supports preservation of the analytical profile recorded at time of testing. Handling notes: Where specific handling precautions apply — for light-sensitive compounds, moisture-sensitive materials, or compounds with specific reconstitution requirements — these may appear in COA notes or supplementary product documentation.For a comprehensive guide to storage and handling in a laboratory research context, see Storage & Handling Best Practices.
---
What a COA Can and Cannot Confirm
A COA can confirm:- The chromatographic purity of the lot at time of testing (HPLC)
- The molecular identity of the compound by mass measurement (LC-MS)
- The lot number and test date for traceability
- The physical appearance of the material at dispatch
- Net peptide content, where reported
- Future stability or purity after storage — it is a point-in-time document
- Suitability for human, clinical, veterinary, or diagnostic use
- Biological activity or efficacy in any research model
- Endotoxin content, sterility, or heavy metal levels unless those specific tests are included and reported
- That the material is suitable for any application outside a controlled laboratory research setting
Understanding what a COA does and does not represent is part of responsible handling of RUO research materials. For context on what RUO designation means for documentation, see What Research Use Only Means.
---
Related Phase 1 Peptides Resources
- Understanding Certificates of Analysis — complete field-by-field COA walkthrough
- How to Verify a Peptide COA — methods for cross-checking COA data and evaluating documentation quality
- Lab Testing & Verified Purity — overview of the analytical testing methodology behind COA documentation
- How to Read HPLC Purity Data — chromatogram anatomy and impurity interpretation
- LC-MS Identity Confirmation — deep dive on reading mass spec identity data
- HPLC vs LC-MS: A Researcher's Comparison — how HPLC and LC-MS work together in research peptide COA documentation
- Peptide Stability and Degradation in Research Context — how the COA test date relates to storage stability
- What Research Use Only Means — RUO designation and its implications for documentation
- Analytical Methods Glossary — definitions for HPLC, LC-MS, COA, RUO, and related terms
- View Available Analytical Records — lot-specific HPLC and LC-MS data for Phase 1 Peptides products
---
What should researchers look for on a peptide COA?Key fields include: the product name and lot number (confirming the document applies to the specific material received), the test date, the HPLC purity percentage and chromatogram, the LC-MS observed and theoretical molecular weight, the physical appearance description, and the recommended storage conditions. A complete COA provides two independent lines of analytical evidence — HPLC purity and LC-MS identity — along with lot traceability information.
Does HPLC purity confirm peptide identity?Not directly. HPLC measures chromatographic retention time and the proportion of the UV-detected area attributable to the main compound. While retention time is consistent for a given compound under standardized conditions, it is not a molecular identity confirmation — a structurally modified peptide with similar chromatographic behavior could appear in the same position. Identity confirmation requires mass spectrometry (LC-MS) or equivalent molecular characterization.
Does LC-MS confirm purity?No. Standard LC-MS detects the dominant molecular species and confirms its mass. It does not quantify the proportion of compound versus impurities in the sample. Purity determination requires HPLC or a comparable chromatographic quantification method. HPLC and LC-MS are complementary — each answers a different analytical question.
Can a COA confirm suitability for human use?No. A COA records analytical test results — HPLC purity, LC-MS identity, and related data — for research characterization purposes. These results do not assess biological activity, sterility, endotoxin content, or any parameter relevant to human, clinical, veterinary, or diagnostic use. Research-grade COA documentation is applicable within a laboratory research context only.
Why do lot numbers matter on COA documents?The lot number ties the analytical data to a specific production batch. COA results are lot-specific — purity and identity data reported on one COA apply only to that tested lot. A COA from a different batch does not represent the material in a separately produced lot. Lot traceability is important for laboratory records, reproducibility documentation, and any supplier follow-up regarding a specific batch.
Where can researchers review available COA documentation?Lot-specific analytical records — HPLC chromatograms and LC-MS identity data where available — are published on the Phase 1 Peptides lab-tests page and on individual product pages. For guidance on reading and interpreting this documentation, see Understanding Certificates of Analysis, How to Read HPLC Purity Data, and How to Verify a Peptide COA.
All Phase 1 Peptides products are supplied exclusively for laboratory research and in vitro studies. They are not intended for human or animal consumption, clinical use, or therapeutic application.